References
- Alger JR, Frank JA, Bizzi A . 1990. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177:633–641.
- Barker PB, Glickson JD, Bryan N. 1993. In vivo magnetic resonance spectroscopy of human brain tumours. Topics in Magnetic Resonance Imaging 5:32–45.
- Boss EA, Moolenaar SH, Massuger LF . 2000. High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid. NMR in Biomedicine 13:297–305.
- Burtscher IM, Holtas S. 2001. Proton MR spectroscopy in clinical routine. Journal of Magnetic Resonance Imaging 13:560–567.
- Celik O, Hascalik S, Sarac K . 2005. Magnetic resonance spectroscopy of premalignant and malignant endometrial disorders: a feasibility of in vivo study. European Journal of Obstetrics, Gynecology, and Reproductive Biology 118:241–245.
- Kuesel AC, Briere KM, Halliday WC . 1996. Mobile lipid accumulation in necrotic tissue of high-grade astrocytomas. Anticancer Research 16:1485–1490.
- Mahon MM, Cox IJ, Dina R . 2004. (1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumor load. Journal of Magnetic Resonance Imaging 19:356–364.
- Okada T, Harada M, Matsuzaki K . 2001. Evaluation of female intrapelvic tumors by clinical proton MR spectroscopy. Journal of Magnetic Resonance Imaging 13:912–917.
- Sarac K, Celik O, Hascalik S . 2004. In vivo proton magnetic resonance spectroscopy in the evaluation of the endometrium. Acta Obstetricia et Gynecologica Scandinavica 83:751–757.
- Smith ICP, Stewart LC. 2002. Magnetic resonance spectroscopy in medicine: clinical impact. Progress in Nuclear Magnetic Resonance Spectroscopy 40:1–34.
- Tien RD, Lai PH, Smith JS . 1996. Single-voxel proton brain spectroscopy exam (Probe/SV) in patients with primary brain tumours. American Journal of Roentgenology 167:201–209.